Efficacy and Safety of Nilotinib in CML-CP

Clinical trial NCT03332511 · COMPLETED

Trial details

NCT number: NCT03332511
Sponsor: Seoul National University Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia, Chronic Phase

Start date: 2013-05-06
Primary completion: 2016-10-24
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.